Noile-Immune Biotech (TSE:4893) Scaled Net Operating Assets : 0.02 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Noile-Immune Biotech's operating assets for the quarter that ended in Mar. 2024 was 円216.5 Mil. Noile-Immune Biotech's operating liabilities for the quarter that ended in Mar. 2024 was 円107.2 Mil. Noile-Immune Biotech's Total Assets for the quarter that ended in Dec. 2023 was 円5,778.9 Mil. Therefore, Noile-Immune Biotech's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.02.

Noile-Immune Biotech Scaled Net Operating Assets Historical Data

The historical data trend for Noile-Immune Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Scaled Net Operating Assets Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.02

-0.05

0.03

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial				-	-	0.05	0.02	0.02

Competitive Comparison of Noile-Immune Biotech's Scaled Net Operating Assets

For the Biotechnology subindustry, Noile-Immune Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noile-Immune Biotech's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noile-Immune Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Noile-Immune Biotech's Scaled Net Operating Assets falls into.

Noile-Immune Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Noile-Immune Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(223.255	-	91.494)	/	4641.032
=	0.03

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5778.946	-	5555.691
=	223.255

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	91.494	-	0	-	0
=	91.494

Noile-Immune Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(216.515	-	107.217)	/	5778.946
=	0.02

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5456.992	-	5240.477
=	216.515

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	107.217	-	0	-	0
=	107.217

Noile-Immune Biotech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines